SynthesisFrontiers in public health2021

Cost-Effectiveness Analysis of Vedolizumab Compared With Infliximab in Anti-TNF-α-Naïve Patients With Moderate-to-Severe Ulcerative Colitis in China.

Ting Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.